The Cardiac Marker Testing Market was valued at USD 4.8 billion in 2023 and is expected to expand at a CAGR of 10.3% from now until 2030, ultimately reaching USD 9.7 billion. The rising incidence of cardiovascular diseases will drive the growth of the Cardiac Marker Testing Market.

The increasing incidence of cardiovascular diseases, along with technological progress and a growing elderly demographic, fuels the cardiac biomarker testing industry. There are prospects in point-of-care testing, improving accessibility, and continual investments in biomarker research and development, which suggest better diagnostic methods. The convergence of these drivers and opportunities indicates a future where effective, accurate, and easily accessible cardiac testing will be essential in addressing and reducing the effects of cardiovascular diseases.

Cardiac Marker Testing Market

The combination of telemedicine and remote monitoring with cardiac biomarker testing revolutionizes cardiovascular healthcare. Patients can consult with healthcare professionals remotely through telemedicine, receiving guidance tailored to biomarker information. Continuous monitoring enables timely interventions and improves accessibility, allowing patients to conduct tests from the comfort of their homes. This smooth integration represents a significant shift towards patient-focused, remote cardiovascular care, improving diagnostics and facilitating prompt interventions.

Health Technology Insights: Amino Health Partners with Bend Health to Boost Youth Mental Health

Instruments segment to register significant growth over the forecast period of 2024-2030. Cardiac marker testing instruments encompass diverse technologies, including ELISA, chemiluminescence, immunofluorescence, immunochromatography, and other innovative methods. These instruments play a pivotal role in accurately measuring cardiac biomarkers, contributing to advancements in cardiovascular diagnostics. This diversity in instrument types ensures flexibility and accuracy in cardiovascular diagnostics, catering to the varied requirements of clinical laboratories and healthcare facilities.

In cardiac marker testing at POCT facilities, rapid on-site diagnostics for cardiovascular conditions are conducted using portable testing devices. This enables immediate results at the bedside or in outpatient settings, particularly for markers such as Troponins. Designed for simplicity and speed, these tests are suitable for decentralized healthcare settings such as emergency departments, ambulances, or clinics, facilitating timely interventions and improving patient outcomes.

Health Technology Insights: Advarra Unveils Oncology Research Pulse

The growth of the North American market is attributed to several factors, including the strong presence of major industry players in the region. Furthermore, cardiovascular disease remains the leading cause of mortality across genders and ethnicities in the US. A staggering statistic highlights the reality, with one person succumbing to cardiovascular disease every 33 seconds, contributing to approximately 695,000 deaths in the country in 2021.

The cardiac marker testing market is characterized by the presence of various small and big players. The major market players include Abbott, Becton, Dickinson and Company, bioMérieux, Bio-Rad, Danaher, DiaSorin, LSI Medience, PerkinElmer, Quidel, Roche, Siemens, Thermo Fisher Scientific, and Tosoh, amongst others.  In a competitive market landscape, players are swiftly embracing advanced technologies to enhance cardiac marker testing operations and bolster their competitive stance through strategic initiatives, including mergers, acquisitions, and the introduction of new products.

TRENDING REPORTS

Health Technology Insights: Hyde Park Capital Advises VitalTech on Its Sale to CoachCare

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

About  Intent Market Research™

Intent Market Research (IMR) is a market research firm dedicated to providing unique, data-driven insights that support sustainable and inclusive business growth. We specialize in comprehensive market research reports and consulting services across diverse industries including chemicals, healthcare, automotive, energy, packaging, and semiconductor & electronics.

Our approach centers on delivering transformative market intelligence through syndicated reports, custom research, and strategic consulting services. We work closely with clients to develop tailored solutions that address unique business challenges, offering quantifiable market insights and forward-looking strategies. Our team of expert analysts and consultants combines cutting-edge competencies with a robust research methodology to help businesses explore new markets, develop innovative products, and uncover growth opportunities.

At IMR, we are committed to ethical standards and compliance, conducting research with transparency and integrity. We prioritize data privacy, maintain strict confidentiality, and adhere to industry regulations. Our goal is to empower businesses with comprehensive, fact-based insights that drive sustainable advantages and meaningful organizational change.

To find out more, visit Intent Market Research™ or follow us on LinkedIn. 

Contact:
Mr. Jay Kumar
Intent Market Research

1846 E Innovation Park DR Site
100 ORO Valley
AZ 85755

USA: +1 463-583-2713
Email: sales@intentmarketsearch.com